Korea Bio-Gen Co.Ltd (318000) — Free Cash Flow Generation Index
Korea Bio-Gen Co.Ltd (318000) has a Free Cash Flow Generation Index of 0.97x as of June 2026. Free cash flow of ₩1.47 Billion represents 1% of operating cash flow (₩1.51 Billion). Explore 318000 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Korea Bio-Gen Co.Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Korea Bio-Gen Co.Ltd across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Korea Bio-Gen Co.Ltd generate cash.
Annual Free Cash Flow Generation for Korea Bio-Gen Co.Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Korea Bio-Gen Co.Ltd. Check Korea Bio-Gen Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.94x | ₩6.88 Billion | ₩7.34 Billion | ₩462.42 Million | ▲ +586.6% |
| 2024 | -0.19x | ₩-826.14 Million | ₩4.29 Billion | ₩5.12 Billion | ▼ -125.9% |
| 2023 | 0.74x | ₩7.05 Billion | ₩9.47 Billion | ₩2.42 Billion | ▲ +301.2% |
| 2022 | -0.37x | ₩-617.53 Million | ₩1.67 Billion | ₩2.29 Billion | ▼ -255.8% |
| 2021 | 0.24x | ₩734.39 Million | ₩3.09 Billion | ₩2.36 Billion | ▼ -64.1% |
| 2020 | 0.66x | ₩1.71 Billion | ₩2.58 Billion | ₩872.46 Million | ▲ +658.8% |
| 2019 | 0.09x | ₩266.28 Million | ₩3.05 Billion | ₩2.55 Billion | ▼ -93.9% |
| 2018 | 1.42x | ₩2.83 Billion | ₩1.98 Billion | ₩840.93 Million | ▼ -8.8% |
| 2017 | 1.56x | ₩2.16 Billion | ₩1.38 Billion | ₩777.66 Million | — |